Cargando…
Vav2 Pharmaco-Mimetic Mice Reveal the Therapeutic Value and Caveats of the Catalytic Inactivation of a Rho Exchange Factor
The current paradigm holds that the inhibition of Rho guanosine nucleotide exchange factors (GEFs), the enzymes that stimulate Rho GTPases, can be a valuable therapeutic strategy to treat Rho-dependent tumors. However, formal validation of this idea using in vivo models is still missing. In this con...
Autores principales: | Lorenzo-Martín, L. Francisco, Rodríguez-Fdez, Sonia, Fabbiano, Salvatore, Abad, Antonio, García-Macías, María C., Dosil, Mercedes, Cuadrado, Myriam, Robles-Valero, Javier, Bustelo, Xosé R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610363/ https://www.ncbi.nlm.nih.gov/pubmed/32528129 http://dx.doi.org/10.1038/s41388-020-1353-x |
Ejemplares similares
-
The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
por: Lorenzo-Martín, L. Francisco, et al.
Publicado: (2022) -
New Functions of Vav Family Proteins in Cardiovascular Biology, Skeletal Muscle, and the Nervous System
por: Rodríguez-Fdez, Sonia, et al.
Publicado: (2021) -
Distinct Roles of Vav Family Members in Adaptive and Innate Immune Models of Arthritis
por: Conde, Javier, et al.
Publicado: (2021) -
The Vav GEF Family: An Evolutionary and Functional Perspective
por: Rodríguez-Fdez, Sonia, et al.
Publicado: (2019) -
Cancer‐associated mutations in VAV1 trigger variegated signaling outputs and T‐cell lymphomagenesis
por: Robles‐Valero, Javier, et al.
Publicado: (2021)